Jazz Financing I DAC; is an Irish incorporated designated activity company (limited by shares). They are a trading entity responsible for the treasury activities of Jazz Pharmaceuticals group of companies, including cash pooling, liquidity, counterparty and currency risk management. They are also involved in the management and raising of debt and managing the relationship with banks and the capital markets and have provided certain guarantees and security in respect of our own, the Parent’s and certain of the Parent's subsidiaries’ indebtedness thereunder. The net proceeds from the initial offering was US$1,851,681,957.80. They have used the net proceeds from this offering to lend to an affiliate within the Jazz Pharmaceuticals group. The Notes are in registered form. The Current Noteholder is Jazz Pharmaceuticals International Limited.
Jazz Financing I DAC; US$2,530,000,000 - 5.2% Fixed Rate Notes Program due 2025;
TRADING HOURS | LOCATION |
---|---|
08:30-09:00 Price Discovery | Exchange House |
09:00-16:30 Continuous Trading | 110 Pitts Bay Road |
Pembroke, Bermuda | |
CONTACT DETAILS | MAILING ADDRESS |
TEL: +1 (441) 292 7212 | P.O. Box HM 1369 |
FAX: +1 (441) 292 7619 | Hamilton HMFX |
Contact Us (info@bsx.com) |
DISCLAIMER |
---|
The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website. |